Multomic Analysis of Sepsis Molecular Subtypes: Discovery of Candidate Biomarkers and Potential Drug Targets
Chemical Biology & Drug Design · 2026-11 · 108 (5)
DOI: 10.1111/cbdd.70436 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Biology & Drug Design, online erschienen am 17.11.2026. Verfasst von Xiaomin Yu und 5 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sichuan Provincial Administration of Traditional Chinese Medicine.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis exhibits significant heterogeneity, and molecular subtyping may help characterize this heterogeneity. Based on public transcriptomic and single‐cell data from sepsis patients, this study used the NMF algorithm to classify patients into three molecular subtypes. Subtype C1 is characterized by metabolic disturbances and innate immune activation; subtype C2 is characterized by adaptive immune activation and has the highest survival rate (88.9%); subtype C3 is characterized by epigenetic dysregulation and the lowest observed 28‐day survival proportion (73.8%). Machine learning identified four candidate subtype‐associated genes—MMP8, KCNMA1, HPGD, and FAM102A—and the four‐gene SVM classifier showed exploratory internal subtype separability (accuracy, 78.2%; one‐vs‐all AUCs, 0.894–0.928). Network pharmacology screening identified 113 traditional Chinese medicine compounds and two Western drugs. Single‐cell analysis characterized the cell‐type‐specific expression patterns of these genes and identified exploratory expression‐associated communication patterns. In vitro experiments showed that HPGD protein expression was increased in LPS‐stimulated AML‐12 cells, whereas treatment with droperidol or Ganoderma lucidum extract was associated with lower HPGD expression levels. This study proposes a potential molecular subtyping framework and prioritizes candidate biomarkers and compounds for further validation.
Förderung
- Sichuan Provincial Administration of Traditional Chinese Medicine
Zitieren
APA
Yu, X., Deng, Y., Song, Q., Xu, X., Long, K., & Guo, X. (2026). Multomic Analysis of Sepsis Molecular Subtypes: Discovery of Candidate Biomarkers and Potential Drug Targets. Chemical Biology & Drug Design, 108(5). https://doi.org/10.1111/cbdd.70436
Vancouver
Yu X, Deng Y, Song Q, Xu X, Long K, Guo X. Multomic Analysis of Sepsis Molecular Subtypes: Discovery of Candidate Biomarkers and Potential Drug Targets. Chemical Biology & Drug Design. 2026;108(5). doi:10.1111/cbdd.70436
BibTeX
@article{Yu2026,
author = {Yu, Xiaomin and Deng, Yuqian and Song, Qiang and Xu, Xinyu and Long, Kunlan and Guo, Xiaohui},
title = {Multomic Analysis of Sepsis Molecular Subtypes: Discovery of Candidate Biomarkers and Potential Drug Targets},
journal = {Chemical Biology & Drug Design},
year = {2026},
volume = {108},
number = {5},
doi = {10.1111/cbdd.70436}
}
EUVIMED